2003 (19 POSTS)
Sarangapani R, Gentry PR, Covington TR , Teeguarden JG, and Clewell HJ. 2003. Evaluation of the potential impact of age- and gender-specific lung morphology and ventilation rate on the dosimetry of vapors. Inhal Toxicol 15(10):987–1016.
View Abstract
Publication: Manuscripts
Gentry PR, Covington TR , Clewell HJ, Andersen ME. 2003. Application of a physiologically based pharmacokinetic model for reference dose and reference concentration estimation for acetone. J Toxicol Environ Health A 66(23):2209–2225.
View Abstract
Publication: Manuscripts
Choksi NY , Jahnke GD, St Hilaire C, Shelby MD. 2003. Role of thyroid hormones in human and laboratory animal reproductive health. Birth Defects Res B Develop Reprod Toxicol 68(6):479–491; doi: 10.1210/er.2015-1106 .
View Abstract
Publication: Manuscripts
Clewell H, Crump K, Covington T , Gentry R, Yeager J. A risk assessment for inhaled arsenic based on urinary arsenic concentration using a pharmacokinetic model. Poster presented at the Society of Toxicology Annual Meeting, Salt Lake City, UT, March 2003.
Publication: Abstracts and Presentations
2002 (10 POSTS)
Roberts SM, Jordan KE, Warren DA, Britt JK , James RC. 2002. Evaluation of the carcinogenicity of 1,1-dichloroethylene (vinylidene chloride). Regul Toxicol Pharmacol 35(1):44-55; doi: 10.1006/rtph.2001.1518 .
View Abstract
Publication: Manuscripts
Haws L . Toxicology and risk assessment resources and practices in the state of Texas. Presented at the USEPA Region 6 States Risk Assessment Roundtable, Dallas, TX, April 2002.
Publication: Abstracts and Presentations
Clewell HJ, Teeguarden J, McDonald T, Sarangapani R, Lawrence G, Covington T , Gentry R, Shipp A. 2002. Review and evaluation of the potential impact of age and gender-specific pharmacokinetic differences on tissue dosimetry. Crit Rev Toxicol 32(5):329–389.
View Abstract
Publication: Manuscripts
Gentry PR, Covington TR , Andersen ME, Clewell HJ. 2002. Application of a physiologically based pharmacokinetic model for isopropanol in the derivation of a reference dose and reference concentration. Regul Toxicol Pharmacol 36:51–68.
View Abstract
Publication: Manuscripts
Grasty RC , Grey BE, Thibodeaux J, Lau C, Rogers JM . Critical period for increased neonatal mortality induced by perfluorooctane sulfonate (PFOS) in the rat. Society of Toxicology 41st Annual Meeting, Nashville, TN, March 2002.
Publication: Abstracts and Presentations
Strobel HW, Thompson CM , Antonovic L. 2001. Cytochromes P450 in brain: Function and significance. Curr Drug Metabol 2(2):199–214; doi: 10.2174/1389200013338577 .
View Abstract
Publication: Manuscripts
Booth RG, Moniri NH, Bakker RA, Choksi NY , Nix WB, Timmerman H, Leurs R. 2002. A novel phenylaminotetralin radioligand reveals a sub-population of histamine H1 receptors. J Pharmacol Exper Therapeut 302(1):328–336; doi: 10.1124/jpet.302.1.328 .
View Abstract
Publication: Manuscripts
Staskal DF , DeVito MJ, Ross DG, Birnbaum LS. Inhibition of human and rat CYP1A2 by TCDD and dioxin-like chemicals. Society of Toxicology 41st Annual Meeting, Nashville, TN, March 2002.
Publication: Abstracts and Presentations
Lea IA , Widgren EE, O’Rand MG. 2002. Analysis of recombinant mouse zona pellucida protein 2 (ZP2) constructs for immunocontraception. Vaccine 20(11–12):1515–1523; doi: 10.1016/S0264-410X(01)00514-X .
View Abstract
Publication: Manuscripts
Gentry R, Teeguarden J, Sarangapani R, Covington T , Lawrence G, McDonald T, Shipp A, Clewell H. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences in tissue dosimetry. Poster presented at the Society of Toxicology Annual Meeting, Nashville, TN, March 2002.
Publication: Abstracts and Presentations
2001 (8 POSTS)
Covington TR , Teeguarden J, Sarangapani R, Gentry PR, Clewell HJ. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Presentation at the Annual Society for Risk Analysis Conference, Seattle, WA, December 2001.
Publication: Abstracts and Presentations
Clewell HJ, Gentry PR, Gearhart JM, Covington TR , Banton MI, Andersen ME. 2001. Development of a physiologically based pharmacokinetic model of isopropanol and its metabolite acetone. Toxicol Sci 63:160–172.
View Abstract
Publication: Manuscripts
Lau C, Mole ML, Copeland FM, Rogers JM , Kavlock RJ, Shuey DL, Cameron AM, Ellis DH, Logsdon TR, Merriman J, Setzer RW. 2001. Toward a biologically-based dose-response model for the developmental toxicity of 5-fluorouracil in the rat: Acquisition of experimental data. Toxicol Sci 59(1):37–48; doi: 10.1093/toxsci/59.1.37 .
View Abstract
Publication: Manuscripts
Setzer RW, Lau C, Mole ML, Copeland FM, Rogers JM , Kavlock RJ. 2001. Toward a biologically-based dose-response model for the developmental toxicity of 5-fluorouracil in the rat: A mathematical construct. Toxicol Sci 59(1):49–58; doi: 10.1093/toxsci/59.1.49 .
View Abstract